Blocking assays using anti-NKG2D and anti-DNAM-1 antibodies significantly reduced tumor lysis, indicating that natural killer receptors (NKRs) contribute synergistically with CAR70 signaling to mediate tumor elimination (Figures 2E and 2F).18 The gene discussed is CD226; the disease is neoplasm.